a.k.a. Brands Holding Corp.

NYSE:AKA Stock Report

Market Cap: US$204.6m

a.k.a. Brands Holding Valuation

Is AKA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AKA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AKA ($17.15) is trading above our estimate of fair value ($4.64)

Significantly Below Fair Value: AKA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AKA?

Key metric: As AKA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AKA. This is calculated by dividing AKA's market cap by their current revenue.
What is AKA's PS Ratio?
PS Ratio0.3x
SalesUS$564.59m
Market CapUS$204.61m

Price to Sales Ratio vs Peers

How does AKA's PS Ratio compare to its peers?

The above table shows the PS ratio for AKA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.3x
DBI Designer Brands
0.09x2.6%US$286.4m
GCO Genesco
0.1x1.9%US$345.0m
JILL J.Jill
0.6x1.6%US$387.1m
CURV Torrid Holdings
0.4x0.8%US$422.9m
AKA a.k.a. Brands Holding
0.3x4.2%US$204.6m

Price-To-Sales vs Peers: AKA is expensive based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.3x).


Price to Sales Ratio vs Industry

How does AKA's PS Ratio compare vs other companies in the US Specialty Retail Industry?

43 CompaniesPrice / SalesEstimated GrowthMarket Cap
TA TravelCenters of America
0.1x-0.8%US$1.30b
ODP ODP
0.1x-2.1%US$764.10m
ARKO Arko
0.08x-1.7%US$752.51m
GCO Genesco
0.1x1.9%US$344.96m
AKA 0.3xIndustry Avg. 0.4xNo. of Companies43PS00.61.21.82.43+
43 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AKA is good value based on its Price-To-Sales Ratio (0.3x) compared to the US Specialty Retail industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is AKA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AKA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: AKA is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AKA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$17.15
US$26.00
+51.6%
16.6%US$30.00US$20.00n/a3
Nov ’25US$23.30
US$23.75
+1.9%
17.5%US$30.00US$20.00n/a4
Oct ’25US$19.66
US$21.25
+8.1%
10.2%US$25.00US$20.00n/a4
Sep ’25US$22.22
US$21.25
-4.4%
10.2%US$25.00US$20.00n/a4
Aug ’25US$17.49
US$22.50
+28.6%
6.7%US$25.00US$21.00n/a4
Jul ’25US$15.99
US$22.50
+40.7%
6.7%US$25.00US$21.00n/a4
Jun ’25US$16.95
US$22.50
+32.7%
6.7%US$25.00US$21.00n/a4
May ’25US$19.10
US$11.13
-41.8%
15.7%US$14.00US$9.50n/a4
Apr ’25US$9.90
US$9.63
-2.8%
11.2%US$11.00US$8.00n/a4
Mar ’25US$13.54
US$9.00
-33.5%
19.2%US$12.00US$8.00n/a4
Feb ’25US$9.70
US$9.00
-7.2%
19.2%US$12.00US$8.00n/a4
Jan ’25US$8.05
US$9.00
+11.8%
19.2%US$12.00US$8.00n/a4
Dec ’24US$9.47
US$9.50
+0.3%
19.4%US$12.00US$8.00n/a5
Nov ’24US$6.00
US$11.16
+86.0%
38.7%US$18.00US$4.80US$23.305
Oct ’24US$5.22
US$11.16
+113.8%
38.7%US$18.00US$4.80US$19.665
Sep ’24US$6.01
US$10.90
+81.5%
36.6%US$18.00US$4.80US$22.226
Aug ’24US$6.12
US$19.00
+210.5%
52.9%US$36.00US$6.00US$17.496
Jul ’24US$5.16
US$19.00
+268.2%
52.9%US$36.00US$6.00US$15.996
Jun ’24US$4.92
US$19.00
+286.2%
52.9%US$36.00US$6.00US$16.956
May ’24US$4.14
US$23.49
+466.8%
43.0%US$36.00US$6.00US$19.107
Apr ’24US$6.54
US$25.71
+293.4%
33.4%US$36.00US$12.00US$9.907
Mar ’24US$16.68
US$36.60
+119.4%
28.1%US$48.00US$20.40US$13.548
Feb ’24US$18.24
US$40.05
+119.6%
21.9%US$48.00US$20.40US$9.708
Jan ’24US$15.24
US$40.05
+162.8%
21.9%US$48.00US$20.40US$8.058
Dec ’23US$21.36
US$40.05
+87.5%
21.9%US$48.00US$20.40US$9.478
Nov ’23US$23.64
US$46.05
+94.8%
32.0%US$72.00US$20.40US$6.008

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies